“Nycomed is ours”: Håkan Björklund speaks candidly on the current state of the pharmaceutical industry.
Pharmaceutical manufacturer Nycomed grew from a small, Scandinavian enterprise to one of the world’s 25 largest pharma companies by being better run, better led, and more aggressive than many of its counterparts.
Now a globally recognized pharmaceutical giant, with products in over one hundred countries and 12,000 staff, Nycomed grew dramatically following its acquisition of Altana in 2006.
Most impressively, it tripled profits during a global recession – reporting figures of €74 million in Q2 2009.
In an exclusive interview for MeetTheBoss.tv, CEO Håkan Björklund explains how his style of leadership has created 11 years of solid success, and talks candidly about the pharmaceutical industry and the challenges facing him in 2010.
Håkan confesses that Nycomed’s disputes with generic manufacturers are set to continue, highlighting President Obama’s healthcare reforms as potentially problematic. “There is no question in my mind that not only the US Government, but most of the governments today are stimulating and promoting use of generics as a way of cutting costs,” he says.
“For me it’s more important to figure out a strategy that will continue to be successful rather than being upset with the way government works.”
MeetTheBoss.tv | The Executive Channel
No comments:
Post a Comment